Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm. The post Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs appeared first on MedCity News.

Read More

Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy

That is the title of a paper published today in Current Medical Research and Opinion with co-authors Nadine Zawadzki, Moises Marin, Ivana Audhya, Lauren Sedita, Natasha Kulkarni and Alexa Klimchak. The abstract is below. ObjectivesQuantify caregiver risk preferences to inform the “value of hope” for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of…

Read More

KFF Health News’ ‘What the Health?’: Trump 2.0

The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…

Read More